Correlation Between Novozymes A/S and Symrise Ag
Can any of the company-specific risk be diversified away by investing in both Novozymes A/S and Symrise Ag at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novozymes A/S and Symrise Ag into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novozymes AS B and Symrise Ag PK, you can compare the effects of market volatilities on Novozymes A/S and Symrise Ag and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novozymes A/S with a short position of Symrise Ag. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novozymes A/S and Symrise Ag.
Diversification Opportunities for Novozymes A/S and Symrise Ag
-0.03 | Correlation Coefficient |
Good diversification
The 3 months correlation between Novozymes and Symrise is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Novozymes AS B and Symrise Ag PK in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Symrise Ag PK and Novozymes A/S is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novozymes AS B are associated (or correlated) with Symrise Ag. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Symrise Ag PK has no effect on the direction of Novozymes A/S i.e., Novozymes A/S and Symrise Ag go up and down completely randomly.
Pair Corralation between Novozymes A/S and Symrise Ag
Assuming the 90 days horizon Novozymes AS B is expected to generate 1.8 times more return on investment than Symrise Ag. However, Novozymes A/S is 1.8 times more volatile than Symrise Ag PK. It trades about 0.05 of its potential returns per unit of risk. Symrise Ag PK is currently generating about -0.02 per unit of risk. If you would invest 5,551 in Novozymes AS B on December 30, 2024 and sell it today you would earn a total of 316.00 from holding Novozymes AS B or generate 5.69% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Novozymes AS B vs. Symrise Ag PK
Performance |
Timeline |
Novozymes AS B |
Symrise Ag PK |
Novozymes A/S and Symrise Ag Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Novozymes A/S and Symrise Ag
The main advantage of trading using opposite Novozymes A/S and Symrise Ag positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novozymes A/S position performs unexpectedly, Symrise Ag can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Symrise Ag will offset losses from the drop in Symrise Ag's long position.Novozymes A/S vs. Symrise Ag PK | Novozymes A/S vs. Givaudan SA | Novozymes A/S vs. Sika AG | Novozymes A/S vs. Sika AG ADR |
Symrise Ag vs. Givaudan SA ADR | Symrise Ag vs. Sysmex Corp | Symrise Ag vs. Shin Etsu Chemical Co | Symrise Ag vs. Brenntag AG ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Stocks Directory Find actively traded stocks across global markets |